We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Annual Meeting Offers Industry Education and Entertainment

By LabMedica International staff writers
Posted on 08 Jun 2017

Image: Genome editing with CRISPR-Cas9 offers the potential to treat human genetic disease (Photo courtesy of Feng Zhang).

Image: Genome editing with CRISPR-Cas9 offers the potential to treat human genetic disease (Photo courtesy of Feng Zhang).

Registration has opened for the 2017 annual meeting of the American Association of Clinical Chemistry, which has promised novel and interesting sessions that will highlight emerging science, practices, and technologies across the spectrum of clinical laboratory medicine.

The 69th AACC Annual Scientific Meeting & Clinical Lab Expo will be held in San Diego, CA, USA, from July 30 to August 3. In addition to a strong lineup of plenary speakers, which will be headed by Dr. Jennifer Doudna, professor of chemistry and molecular and cell biology at the University of California, Berkeley (USA) – who will be speaking about advances in CRISPR/Cas9 gene editing technology – there will be a mock courtroom session and two quiz games.

The mock trial session will illustrate the importance of expert witness testimony in resolving litigation associated with toxicology and clinical laboratories. One quiz game will pit the AACC leadership against members of the Society for Young Clinical Laboratorians. The teams will contest various laboratory medicine topics such as oncology and cardiovascular biomarkers, molecular testing, point-of-care testing, therapeutic drug management/toxicology, and over-utilized or outdated tests.

The second quiz game will engage the audience on topics addressing Zika virus, mass spectrometry, antimicrobial resistance, and other infectious disease issues and diagnostic solutions.

A highlight of the conference will be the Qualcomm Tricorder XPRIZE special session. Two participants in this $10 million global competition to develop devices capable of diagnosing at least 13 health conditions and continuously monitoring five vital signs, all with a consumer-friendly interface and weighing no more than five pounds (2.27 kilograms), will present their innovations.

Related Links:
AACC Annual Scientific Meeting & Clinical Lab Expo
University of California, Berkeley

Visit expo >

Gold Member

Quantitative POC Immunoassay Analyzer

EASY READER+

POC Helicobacter Pylori Test Kit
Hepy Urease Test

Clinical Chemistry System

P780

CBM Analyzer

Complete Blood Morphology (CBM) Analyzer

Latest AACC 2017 News

Channels

Clinical Chemistry

view channel

New Blood Test Index Offers Earlier Detection of Liver Scarring

Metabolic fatty liver disease is highly prevalent and often silent, yet it can progress to fibrosis, cirrhosis, and liver failure. Current first-line blood test scores frequently return indeterminate results,... Read more

Image: One of 32 sensors in the electronic nose (Photo courtesy of Linköping University)

Electronic Nose Smells Early Signs of Ovarian Cancer in Blood

Ovarian cancer is often diagnosed at a late stage because its symptoms are vague and resemble those of more common conditions. Unlike breast cancer, there is currently no reliable screening method, and... Read more

Simple Blood Test Offers New Path to Alzheimer’s Assessment in Primary Care

Timely evaluation of cognitive symptoms in primary care is often limited by restricted access to specialized diagnostics and invasive confirmatory procedures. Clinicians need accessible tools to determine... Read more

Existing Hospital Analyzers Can Identify Fake Liquid Medical Products

Counterfeit and substandard medicines remain a serious global health threat, with World Health Organization estimates suggesting that 10.5% of medicines in low- and middle-income countries are either fake... Read more

Molecular Diagnostics

view channel

New Test Detects Alzheimer’s by Analyzing Altered Protein Shapes in Blood

Alzheimer’s disease begins developing years before memory loss or other symptoms become visible. Misfolded proteins gradually accumulate in the brain, disrupting normal cellular processes.... Read more

Image: Proteomic analysis of cerebrospinal fluid revealed a set of markers that better distinguishes MS from related inflammatory diseases (Photo courtesy of TUM, adapted by MPI of Biochemistry)

New Diagnostic Markers for Multiple Sclerosis Discovered in Cerebrospinal Fluid

Multiple sclerosis (MS) affects nearly three million people worldwide and can cause symptoms such as numbness, visual disturbances, fatigue, and neurological disability. Diagnosing the disease can be challenging... Read more

Cell-Free DNA Predicts Bloodstream Infections in Children with Leukemia

Bloodstream infections are a major threat to children undergoing intensive leukemia treatment. Chemotherapy weakens the immune system, allowing bacteria and fungi to trigger sepsis, prolonged hospital... Read more

Study Uses Blood Samples to Identify Diseases Years Before They Start

Chronic diseases such as lupus, rheumatoid arthritis, Crohn’s disease, colon cancer, and heart failure often develop silently for years before symptoms appear. By the time they are diagnosed, significant... Read more

Hematology

view channel

$Image: Hemex Health’s Gazelle platform is designed to rapidly separate and detect hemoglobin fractions and variants using miniaturized electrophoresis technology (photo courtesy of Hemex Health)$

Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis

Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more

New Guidelines Aim to Improve AL Amyloidosis Diagnosis

Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more

Image: The new device can fit in the palm and is capable of measuring the quality of red blood cells (Photo courtesy of Xiaoyun Ding)

Fast and Easy Test Could Revolutionize Blood Transfusions

Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more

Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow

High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more

Immunology

view channel

Image: The study identified a distinct immune signature associated with treatment-resistant myasthenia gravis (Dodd, Katherine C. et al., Med (2026). DOI: 10.1016/j.medj.2025.100987)

Immune Signature Identified in Treatment-Resistant Myasthenia Gravis

Myasthenia gravis is a rare autoimmune disorder in which immune attack at the neuromuscular junction causes fluctuating weakness that can impair vision, movement, speech, swallowing, and breathing.... Read more

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Microbiology

view channel

Blood-Based Viral Signature Identified in Crohn’s Disease

Crohn’s disease is a chronic inflammatory intestinal disorder affecting approximately 0.4% of the European population, with symptoms and progression that vary widely. Although viral components of the microbiome... Read more

Image: The findings suggest that interactions between gut bacteria and the viruses they harbor may contribute to colorectal cancer development (photo courtesy of Adobe Stock)

Hidden Gut Viruses Linked to Colorectal Cancer Risk

Colorectal cancer (CRC) remains a leading cause of cancer mortality in many Western countries, and existing risk-stratification approaches leave substantial room for improvement. Although age, diet, and... Read more

Three-Test Panel Launched for Detection of Liver Fluke Infections

Parasitic liver fluke infections remain endemic in parts of Asia, where transmission commonly occurs through consumption of raw freshwater fish or aquatic plants. Chronic infection is a well-established... Read more

Image: NG-TEST Candida auris is the first lateral-flow immunoassay specifically designed to identify C. auris from cultured specimens within 15 minutes (Photo courtesy of NG Biotech)

Rapid Test Promises Faster Answers for Drug-Resistant Infections

Drug-resistant pathogens continue to pose a growing threat in healthcare facilities, where delayed detection can impede outbreak control and increase mortality. Candida auris is notoriously difficult to... Read more

Pathology

view channel

Molecular Imaging to Reduce Need for Melanoma Biopsies

Melanoma is the deadliest form of skin cancer and accounts for the vast majority of skin cancer-related deaths. Because early melanomas can closely resemble benign moles, clinicians often rely on visual... Read more

Urine Specimen Collection System Improves Diagnostic Accuracy and Efficiency

Urine testing is a critical, non-invasive diagnostic tool used to detect conditions such as pregnancy, urinary tract infections, metabolic disorders, cancer, and kidney disease. However, contaminated or... Read more

Image: The AI-powered 3D cytology platform detects abnormal cells with near-expert accuracy (Photo courtesy of CYBO)

AI-Powered 3D Scanning System Speeds Cancer Screening

Cytology remains a cornerstone of cancer detection, requiring specialists to examine bodily fluids and cells under a microscope. This labor-intensive process involves inspecting up to one million cells... Read more

Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Technology

view channel

Image: The AI system analyzes diverse inputs in order to make a diagnosis based on traceable reasoning (Zhao, W., Wu, C., Fan, Y. et al. Nature (2026). doi.org/10.1038/s41586-025-10097-9)

AI Model Outperforms Clinicians in Rare Disease Detection

Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more

AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection

Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read more

Image: The model estimates when Alzheimer’s symptoms will begin based on the accumulation of amyloid and tau proteins in the brain (Photo courtesy of Sara Moser/WashU Medicine)

Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms

More than 7 million Americans live with Alzheimer’s disease, and related health and long-term care costs are projected to reach nearly USD 400 billion in 2025. The disease has no cure, and symptoms often... Read more

mage: The AI-derived MYCN niche score predicts liver cancer risk before tumors form (Photo courtesy of Adobe Stock)

AI-Powered Biomarker Predicts Liver Cancer Risk

Liver cancer, or hepatocellular carcinoma, causes more than 800,000 deaths worldwide each year and often goes undetected until late stages. Even after treatment, recurrence rates reach 70% to 80%, contributing... Read more

Industry

view channel

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more